| Cyrus Chi-ho Wong, MD | |
|
800 5th Ave Ste 500, Fort Worth, TX 76104-7304 | |
| (817) 250-4280 | |
| Not Available |
| Full Name | Cyrus Chi-ho Wong |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 16 Years |
| Location | 800 5th Ave Ste 500, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306010707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | Q3993 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guardian Healthcare | Fort worth, TX | Home health agency |
| Texas Health Harris Methodist Hospital Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Health Physicians Group | 4385535954 | 1182 |
| The West Texas Rehabilitation Center | 2860301215 | 361 |
News Archive
Adeona Pharmaceuticals, Inc., announced today that on July 6, 2010, it completed an equity financing of $1 million with a single institutional investor, Seaside 88, L.P. The financing involved the sale of 1,212,121 registered shares of common stock and no warrants. Enclave Capital served as placement agent and will receive a 7% cash commission and 5-year warrants to acquire 60,606 shares of Adeona at $1.32 per share. The use of proceeds is intended for general corporate purposes.
Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia (AML) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.
More than half of all drugs given to patients work by targeting a particular type of "docking station," or receptor, found on body cells, to steer the cell's machinery toward healing an illness.
A new study suggests an estimated 46.3 percent of adolescents with an autism spectrum disorder (ASD) were the victims of bullying, according to a report published this week in the American Medical Association's Archives of Pediatrics & Adolescent Medicine.
A new study has examined the effects on the heart of treating multiple narrowed arteries - rather than just one - at the time of a heart attack.
› Verified 7 days ago
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
Adeona Pharmaceuticals, Inc., announced today that on July 6, 2010, it completed an equity financing of $1 million with a single institutional investor, Seaside 88, L.P. The financing involved the sale of 1,212,121 registered shares of common stock and no warrants. Enclave Capital served as placement agent and will receive a 7% cash commission and 5-year warrants to acquire 60,606 shares of Adeona at $1.32 per share. The use of proceeds is intended for general corporate purposes.
Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia (AML) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.
More than half of all drugs given to patients work by targeting a particular type of "docking station," or receptor, found on body cells, to steer the cell's machinery toward healing an illness.
A new study suggests an estimated 46.3 percent of adolescents with an autism spectrum disorder (ASD) were the victims of bullying, according to a report published this week in the American Medical Association's Archives of Pediatrics & Adolescent Medicine.
A new study has examined the effects on the heart of treating multiple narrowed arteries - rather than just one - at the time of a heart attack.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cyrus Chi-ho Wong, MD 800 5th Ave Ste 500, Fort Worth, TX 76104-7304 Ph: (817) 250-4280 | Cyrus Chi-ho Wong, MD 800 5th Ave Ste 500, Fort Worth, TX 76104-7304 Ph: (817) 250-4280 |
News Archive
Adeona Pharmaceuticals, Inc., announced today that on July 6, 2010, it completed an equity financing of $1 million with a single institutional investor, Seaside 88, L.P. The financing involved the sale of 1,212,121 registered shares of common stock and no warrants. Enclave Capital served as placement agent and will receive a 7% cash commission and 5-year warrants to acquire 60,606 shares of Adeona at $1.32 per share. The use of proceeds is intended for general corporate purposes.
Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia (AML) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.
More than half of all drugs given to patients work by targeting a particular type of "docking station," or receptor, found on body cells, to steer the cell's machinery toward healing an illness.
A new study suggests an estimated 46.3 percent of adolescents with an autism spectrum disorder (ASD) were the victims of bullying, according to a report published this week in the American Medical Association's Archives of Pediatrics & Adolescent Medicine.
A new study has examined the effects on the heart of treating multiple narrowed arteries - rather than just one - at the time of a heart attack.
› Verified 7 days ago
Anita Praful Bhansali, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 | |
Abdolreza Siadati, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Gregory Alan Ward, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 9th Ave, Suite 201, Fort Worth, TX 76104 Phone: 817-870-5094 Fax: 817-885-7352 | |
Philip C Bechtel, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Yves J. Meyer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104 Phone: 817-820-4280 Fax: 817-820-4281 | |
Dr. Atif Haque, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave Ste A1131, Fort Worth, TX 76104 Phone: 817-912-9250 | |
Adrian Timothy Harvey, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 |